Drug safety
Pharmacovigilance (PV), also known as Drug Safety, aims to enhance patient care and patient safety in relation to use of medicines.
According to the World Health Organization (WHO) PV is defined as the science and activities relating to:
- The detection,
- understanding &
- prevention of adverse effects or any other drug-related problem.
PV is a continuously risk-benefit monitoring and the initiation of necessary actions.
Denk Pharma has elaborated a pharmacovigilance system according to the current European guidelines GVP (good pharmacovigilance practices). Our activities include:
- Collection, evaluation and reporting of relevant cases (spontaneous cases + literature reports)
- Literature research
- Preparation and issue of periodic update safety reports
By the means of
- continuous benefit-risk monitoring
- prevention of side effects / interactions and other drug related problems,
our aim is to protect the health of our patients!
You can also report side effects directly
* Fields marked with an asterisk (*) must be completed.
In the event of a medical emergency, please contact a doctor or the emergency medical service immediately.
If you are reporting on behalf of another person, please make sure that the person concerned agrees to your report and the possible transfer of personal data.
We are legally obliged to record the personal data provided in the context of adverse drug reactions and, under certain circumstances, to report this to the competent authorities. Detailed information on data protection in drug safety (pharmacovigilance) can be found here.
You can report side effects directly
Denk Pharma GmbH & Co. KG
Pharmacovigilance
Prinzregentenstrasse 79
81675 Munich, Germany
Tel +49 (0)89 230029-0
You can reach us by phone:
Monday to Thursday from 8 a.m. to 5 p.m. and Friday from 8 a.m. to 2 p.m.
